UTI Pharma & Healthcare Fund (G) NAV | UTI Mutual Fund | UTI Pharma & Healthcare Fund (G) Investment

MARKET RADAR

SENSEX NIFTY Refresh

You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (G)

SNAPSHOT

SNAPSHOT

Performance

Investment Info

Peers

Portfolio

News and Videos

News Videos

ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:

View Historic Graph From To

Returns (NAV as on May-17-2013)

Period	Returns (%)	Rank #
1 mth	7.2	2
3 mth	13.3	2
6 mth	16.0	2
1 year	27.5	3
2 year	13.9	3
3 year	14.1	2
5 year	16.9	2

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year	Qtr 1	Qtr 2	Qtr 3	Qtr 4	Annual
2013	-4.1	-	-	-	-
2012	6.9	2.3	8.0	4.9	25.0
2011	-7.8	6.1	-7.2	-0.7	-10.0
2010	11.8	8.9	1.4	9.9	37.4
2009	-1.3	18.2	25.1	-0.2	65.7
2008	-15.5	9.8	-0.4	-18.4	-26.4

View where it stands within its peers

* Returns over 1 year are Annualised

Returns Calculator SIP Calculator

EXPAND ALL

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised

	1 mth (%)	3 mth (%)	6 mth (%)	1 yr (%)	2 yr (%)	3 yr (%)	5yr (%)
Fund Returns	7.2	13.3	16.0	27.5	13.9	14.1	16.9
Category avg	7.1	13.2	15.1	31.2	17.2	15.6	18.9
Difference of Fund returns and Category returns	0.1	0.1	0.9	-3.7	-3.3	-1.5	-2.0
Best of category	7.5	13.5	16.9	36.2	22.3	18.9	24.8
Worst of category	6.7	12.9	12.5	27.5	13.9	13.8	15.0
Benchmark returns #	8.5	17.4	22.4	36.8	21.7	19.6	--
Difference of Fund returns and Benchmark returns	-1.3	-4.1	-6.4	-9.3	-7.8	-5.5	16.9

# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type	Open-Ended
Investment Plan	Growth
Launch date	Jun 26, 1999
Benchmark	CNX Pharma
Asset Size (Rs cr)	103.47 (Mar-30-2013)
Minimum Investment	Rs.5000
Last Dividend	N.A. View Dividend History
Bonus	N.A.
Fund Manager	Lalit Nambiar View performance of schemes managed by the Fund Manager
Notes	N.A

Load Details

Entry Load	N.A
Exit Load	1.00%
Load Comments	Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office	UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No.	66786666
Fax No.	26524921
Email	uti@giasbm01.vsnl.net.in
Website	http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)
Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)	3mth (%)	6mth (%)	1yr (%)	3yr (%)	5yr (%)
Reliance Pharma Fund (G)	Not Ranked	652.29	12.9	12.5	30.0	13.8	24.8
SBI Pharma Fund (G)	Not Ranked	66.50	13.5	16.9	36.2	18.9	15.0
UTI Pharma & Health (G)	Not Ranked	103.47	13.3	16.0	27.5	14.1	16.9
* Returns over 1 year are Annualised	More »

Portfolio

Top Holdings (Apr 30, 13)

Equity	Sector	Value (Rs cr)	Asset %
Sun Pharma	Pharmaceuticals	24.86	22.57
Dr Reddys Labs	Pharmaceuticals	18.00	16.34
Cipla	Pharmaceuticals	13.05	11.85
Lupin	Pharmaceuticals	9.76	8.86
GlaxoSmithKline	Pharmaceuticals	7.40	6.71
Divis Labs	Pharmaceuticals	4.83	4.39
Wyeth	Pharmaceuticals	4.25	3.86
Glenmark	Pharmaceuticals	4.00	3.63
Pfizer	Pharmaceuticals	2.82	2.56
Ranbaxy Labs	Pharmaceuticals	2.68	2.43